Cited by 47Schizophrenia research and treatmentMental Health and PsychiatryAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.

Lysaker, Paul H., Kukla, Marina, Dubreucq, Julien, Gumley, Andrew, McLeod, Hamish, Vohs, Jenifer L., Buck, Kelly D., Minor, Kyle S. +5 more·2015·Schizophrenia Research

Abstract

The recalcitrance of negative symptoms in the face of pharmacologic treatment has spurred interest in understanding the psychological factors that contribute to their formation and persistence. Accordingly, this study investigated whether deficits in metacognition, or the ability to form integrated ideas about oneself, others, and the world, prospectively predicted levels of negative symptoms independent of deficits in neurocognition, affect recognition and defeatist beliefs. Participants were 53 adults with a schizophrenia spectrum disorder. Prior to entry into a rehabilitation program, all participants completed concurrent assessments of metacognition with the Metacognitive Assessment Scale-Abbreviated, negative symptoms with the Positive and Negative Syndrome Scale, neurocognition with the MATRICS battery, affect recognition with the Bell Lysaker Emotion Recognition Task, and one form of defeatist beliefs with the Recovery Assessment Scale. Negative symptoms were then reassessed one week, 9weeks, and 17weeks after entry into the program. A mixed effects regression model revealed that after controlling for baseline negative symptoms, a general index of neurocognition, defeatist beliefs and capacity for affect recognition, lower levels of metacognition predicted higher levels of negative symptoms across all subsequent time points. Poorer metacognition was able to predict later levels of elevated negative symptoms even after controlling for initial levels of negative symptoms. Results may suggest that metacognitive deficits are a risk factor for elevated levels of negative symptoms in the future. Clinical implications are also discussed.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2015.06.015

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lysaker, P. H., Kukla, M., Dubreucq, J., Gumley, A., McLeod, H., Vohs, J. L., Buck, K. D., Minor, K. S., Luther, L., Leonhardt, B. L., Belanger, E. A., Popolo, R., & Dimaggio, G.
Affiliations
  • Richard L. Roudebush VA Medical Center (US)
  • University of Glasgow (GB)
  • Indiana University Hospital (US)
  • Indiana University – Purdue University Indianapolis (US)
  • Indiana University School of Medicine (US)
  • University of Indianapolis (US)
  • Centro di Terapia Metacognitiva Interpersonale (IT)
Corresponding author
Lysaker, Paul H.
Venue
Schizophrenia Research
Publisher
Elsevier BV
Published
2015-10
Volume
168
Issue
1-2
Pages
267-272
ISSN
0920-9964 (ISSN-L)
OpenAlex
W1958323847
Cited by
47
References
59
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 4
FWCI
4.33
Type
journal article
Language
en
Open access
closed
Locations
  • Schizophrenia Research (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders
Veterans Administration Rehabilitation Research and Development Service (D 6629R)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
metacognition, negative symptoms
MeSH terms
Metacognition, Cognition Disorders, Emotions, Female, Goals, Humans, Interview, Psychological, Male, Middle Aged, Prognosis, Psychiatric Status Rating Scales, Psychological Tests, Psychotic Disorders, Regression Analysis, Schizophrenia, Schizophrenic Psychology, Self Concept, Cognitive Behavioral Therapy, Recognition, Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review